獣医/動物用ワクチン市場情報 : 2027年までの予測

出版:Market Research Future(マーケットリサーチフューチャー) 出版年月:2022年05月

Animal Vaccines Market : Forecast to 2027

ページ数
価格
シングルユーザライセンス USD4,950
エンタープライズライセンス USD7,250
種別 英文調査報告書

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

Animal Vaccines Market—Forecast to 2027

Market Forecast
Animal Vaccines Market is anticipated to witness a significant CAGR of 7.50% during the projected timeframe with the highest market value of USD 8,013.06 million in 2020. Animal vaccines market study incorporates market size examination and a thorough examination of the producer’s items and administration methodologies. The development of the worldwide animal vaccines market is attributed to the rising zoonotic and ongoing infections in animals and expanding accentuation on animal medical services and inoculation. Be that as it may, high-capacity costs related to vaccines and rigid administrative rules are limiting variables for the animal vaccines market. Also, the development in the number of items sent off to vaccinate different species is inclining toward the development in the animal vaccines market.
As per the World Health Organization (WHO) insights, around 59,000 human passings happen every year by rabies infection across the globe. The spread of such sicknesses is adding to the rising interest in animal vaccines. Moreover, one of the primary purposes behind the developing number of ongoing illnesses is the rising future of pets because of the created medical care offices and great sustenance. Moreover, the animal health future relies upon innovative progression in animal wellbeing and unrivaled patient consideration, the advancement of new items, and the cooperative improvement of vaccines. Pet people are spending a higher sum to look for the best accessible medicines for their partners. This has prompted an expansion in interest in veterinary medical clinics. Moreover, legislatures across the globe are spending a huge sum on veterinary clinics.
Market Segmentation

The segmental analysis of the global Animal Vaccines market is carried out in terms of type, technology, and region.
In terms of type segment, the global market is categorized into Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Porcine Vaccines, and Aquaculture vaccines. The technology segment divides the global market into Toxoid vaccines, Recombinant vaccines, live attenuated vaccines, Inactivated vaccines, and Others.

Regional Analysis

Geographically the global animal vaccines market is spread across four major regions namely the Americas, Europe, Asia-Pacific, and the Middle East, & Africa.
Americas is likely to lead the global animal vaccine market with the largest market share in 2020. The increasing incidences of animal diseases and the increasing pet adoption are expected to boost the regional market in the future. Also, the increasing cases of foot and mouth disease canine parvovirus, and reproductive and respiratory syndrome fuels the further market growth in the Americas.

The European region is anticipated to attain a notable market for animal vaccines followed by the Asia Pacific. The regional market is attributed to the increased population of pets and growing expenditure on research and development. The animal vaccines market in Asia-Pacific is attributed to the rising awareness of animal health, an increase in the livestock population, and the increasing number of cases of animal diseases.

Major Players
The key companies included in the global animal vaccines market research report are Ceva Santé Animale (France), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Biogénesis Bagó S.A.(Argentina), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), and Neogen Corporation (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.


目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING ZOONOTIC AND CHRONIC DISEASES IN ANIMALS

4.2.2 INCREASING EMPHASIS ON ANIMAL HEALTHCARE AND VACCINATION

4.2.3 INCREASED CONSUMPTION OF ANIMAL-BASED PRODUCTS

4.3 RESTRAINT

4.3.1 STRINGENT REGULATORY GUIDELINESANDHIGH STORAGE COSTSASSOCIATED WITH ANIMAL VACCINES

4.4 OPPORTUNITY

4.4.1 RISING INVESTMENTS IN VETERINARY HOSPITALSTO IMPROVE ANIMAL HEALTH

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 RESEARCH & DEVELOPMENT

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19ON THE GLOBAL ANIMAL VACCINES MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT OF COVID-19 ON ANIMAL DISEASE PREVENTION & CONTROL

5.3.3 IMPACT ON MARKET

6 GLOBAL ANIMAL VACCINES MARKET, BY TYPE

6.1 OVERVIEW

6.2 PORCINE VACCINES

6.3 POULTRY VACCINES

6.4 LIVESTOCK VACCINES

6.4.1 BOVINE VACCINES

6.4.2 SMALL RUMINANT VACCINES

6.5 COMPANION ANIMAL VACCINES

6.5.1 CANINE VACCINES

6.5.2 FELINE VACCINES

6.5.3 OTHERS

6.6 AQUACULTUTRE VACCINES

7 GLOBAL ANIMAL VACCINES MARKET, BY TECHNOLOGY

7.1 OVERVIEW

7.2 LIVE ATTENUATED VACCINES

7.3 INACTIVATED VACCINES

7.4 TOXOID VACCINES

7.5 RECOMBINANT VACCINES

7.6 OTHERS

8 GLOBAL ANIMAL VACCINES MARKET, BY REGION

8.1 OVERVIEW

8.2 AMERICAS

8.2.1 NORTH AMERICA

8.2.1.1 US

8.2.1.2 CANADA

8.2.2 SOUTH AMERICA

8.3 EUROPE

8.3.1 WESTERN EUROPE

8.3.1.1 FRANCE

8.3.1.2 GERMANY

8.3.1.3 UK

8.3.1.4 SPAIN

8.3.1.5 ITALY

8.3.1.6 REST OF WESTERN EUROPE

8.3.2 EASTERN EUROPE

8.4 ASIA-PACIFIC

8.4.1 JAPAN

8.4.2 CHINA

8.4.3 INDIA

8.4.4 AUSTRALIA

8.4.5 REPUBLIC OF KOREA

8.4.6 REST OF ASIA-PACIFIC

8.5 MIDDLE EAST & AFRICA

8.5.1 MIDDLE EAST

8.5.2 AFRICA

9 COMPETITIVE LANDSCAPE

9.1 COMPETITIVEOVERVIEW

9.2 MAJOR PLAYERS IN THE GLOBAL ANIMAL VACCINES MARKET

9.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL ANIMAL VACCINES MARKET

9.4 COMPETITIVE BENCHMARKING

9.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ANIMAL VACCINES MARKET

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.6.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES

9.6.2 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS

9.7 MAJOR PLAYERS FINANCIAL MATRIX

9.7.1 REVENUE OF MAJOR PLAYERS, 2020

9.7.2 R&D EXPENDITURE, 2020

10 COMPANY PROFILES

10.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 ZOETIS INC.

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS OFFERED

10.2.4 KEY DEVELOPMENTS.

10.2.5 SWOT ANALYSIS

10.2.6 KEY STRATEGIES

10.3 CEVA SANTÉ ANIMALE

10.3.1 COMPANY OVERVIEW

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS/SERVICES OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 KEY STRATEGIES

10.4 MERCK & CO., INC.

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 SWOT ANALYSIS

10.4.6 KEY STRATEGIES

10.5 ELANCO ANIMAL HEALTH INCORPORATED

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.5.6 KEY STRATEGIES

10.6 VIRBAC

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL OVERVIEW

10.6.3 PRODUCTS OFFERED

10.6.4 KEY DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.6.6 KEY STRATEGIES

10.7 PHIBRO ANIMAL HEALTH CORPORATION

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 KEY STRATEGIES

10.8 HIPRA

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS OFFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 KEY STRATEGIES

10.9 BIOGÉNESIS BAGÓ S.A.

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 KEY STRATEGIES

10.10 NEOGEN CORPORATION

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES

11.2 RELATED REPORTS
LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: ANIMAL VACCINE MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: ANIMAL VACCINE MARKET, FOR PORCINE VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: ANIMAL VACCINE MARKET, FOR POULTRY VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: ANIMAL VACCINE MARKET, FOR LIVESTOCK VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: ANIMAL VACCINE MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: ANIMAL VACCINE MARKET, FOR BOVINE VACCINES, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: ANIMAL VACCINE MARKET, FOR SMALL RUMINANT VACCINES, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: ANIMAL VACCINE MARKET, FOR COMPANION ANIMAL VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: ANIMAL VACCINE MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: ANIMAL VACCINE MARKET, FOR CANINE VACCINES, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: ANIMAL VACCINE MARKET, FOR FELINE VACCINES, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: ANIMAL VACCINE MARKET, FOR OTHERS, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: ANIMAL VACCINE MARKET, FOR AQUACULTUTRE VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: ANIMAL VACCINE MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: ANIMAL VACCINE MARKET, FOR LIVE ATTENUATED VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: ANIMAL VACCINE MARKET, FOR INACTIVATED VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: ANIMAL VACCINE MARKET, FOR TOXOID VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL: ANIMAL VACCINE MARKET, FOR RECOMBINANT VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL: ANIMAL VACCINE MARKET, FOR OTHER VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 22 GLOBAL: ANIMAL VACCINES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 23 AMERICAS: ANIMAL VACCINES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 24 AMERICAS: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 25 AMERICAS: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 26 AMERICAS: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 27 AMERICAS: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 28 NORTH AMERICA: ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 29 NORTH AMERICA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 30 NORTH AMERICA: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 31 NORTH AMERICA: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 32 NORTH AMERICA: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 33 US: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 34 US: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 35 US: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 36 US: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 37 CANADA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 38 CANADA: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 39 CANADA: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 40 CANADA: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 41 SOUTH AMERICA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 42 SOUTH AMERICA: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 43 SOUTH AMERICA: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 44 SOUTH AMERICA: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 45 EUROPE: ANIMAL VACCINES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 46 EUROPE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 47 EUROPE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 48 EUROPE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 49 EUROPE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 50 WESTERN EUROPE: ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 51 WESTERN EUROPE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 52 WESTERN EUROPE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 53 WESTERN EUROPE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 54 WESTERN EUROPE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 55 FRANCE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 56 FRANCE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 57 FRANCE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 58 FRANCE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 59 GERMANY: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 60 GERMANY: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 61 GERMANY: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 62 GERMANY: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 63 UK: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 64 UK: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 65 UK: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 66 UK: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 67 SPAIN: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 68 SPAIN: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 69 SPAIN: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 70 SPAIN: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 71 ITALY: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 72 ITALY: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 73 ITALY: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 74 ITALY: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 75 REST OF WESTERN EUROPE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 76 REST OF WESTERN EUROPE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 77 REST OF WESTERN EUROPE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 78 REST OF WESTERN EUROPE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 79 EASTERN EUROPE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 80 EASTERN EUROPE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 81 EASTERN EUROPE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 82 EASTERN EUROPE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 83 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 84 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 85 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 86 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 87 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 88 JAPAN: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 89 JAPAN: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 90 JAPAN: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 91 JAPAN: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 92 CHINA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 93 CHINA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 94 CHINA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 95 CHINA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 96 INDIA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 97 INDIA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 98 INDIA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 99 INDIA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 100 AUSTRALIA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 101 AUSTRALIA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 102 AUSTRALIA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 103 AUSTRALIA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 104 REPUBLIC OF KOREA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 105 REPUBLIC OF KOREA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 106 REPUBLIC OF KOREA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 107 REPUBLIC OF KOREA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 108 REST OF ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 109 REST OF ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 110 REST OF ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 111 REST OF ASIA-PACIFIC: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 112 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 113 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 114 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 115 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 116 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 117 MIDDLE EAST: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 118 MIDDLE EAST: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 119 MIDDLE EAST: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 120 MIDDLE EAST: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 121 AFRICA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 122 AFRICA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 123 AFRICA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 124 AFRICA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 125 MAJOR PLAYERS IN THE GLOBAL ANIMAL VACCINES MARKET

TABLE 126 THE MOST ACTIVE PLAYERS IN THE GLOBAL ANIMAL VACCINES MARKET

TABLE 127 NEW PRODUCT DEVELOPMENTS/LAUNCHES/PRODUCT LICENSING AGREEMENTS

TABLE 128 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS

TABLE 129 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED

TABLE 130 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS

TABLE 131 ZOETIS INC.: PRODUCTS OFFERED

TABLE 132 ZOETIS INC.: KEY DEVELOPMENTS

TABLE 133 CEVA SANTÉ ANIMALE: PRODUCTS/SERVICES OFFERED

TABLE 134 CEVA SANTÉ ANIMALE: KEY DEVELOPMENTS

TABLE 135 MERCK & CO., INC.: PRODUCTS OFFERED

TABLE 136 MERCK & CO., INC.: KEY DEVELOPMENTS

TABLE 137 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED

TABLE 138 ELANCO ANIMAL HEALTH INCORPORATED: KEY DEVELOPMENTS

TABLE 139 VIRBAC: PRODUCTS OFFERED

TABLE 140 VIRBAC: KEY DEVELOPMENTS

TABLE 141 PHIBRO ANIMAL HEALTH CORPORATION: PRODUCTS OFFERED

TABLE 142 PHIBRO ANIMAL HEALTH CORPORATION: KEY DEVELOPMENTS

TABLE 143 HIPRA: PRODUCTS OFFERED

TABLE 144 HIPRA: KEY DEVELOPMENTS

TABLE 145 BIOGÉNESIS BAGÓ S.A.: PRODUCTS OFFERED

TABLE 146 BIOGÉNESIS BAGÓ S.A.: KEY DEVELOPMENTS

TABLE 147 NEOGEN CORPORATION: PRODUCTS OFFERED

TABLE 148 NEOGEN CORPORATION: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET STRUCTURE: ANIMAL VACCINES MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL ANIMAL VACCINES MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ANIMAL VACCINES MARKET

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBALANIMAL VACCINES MARKET

FIGURE 9 GLOBAL ANIMAL VACCINE MARKET, BY TYPE, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL ANIMAL VACCINE MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: ANIMAL VACCINES MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: ANIMAL VACCINES MARKET SHARE (%), BY REGION, 2020

FIGURE 13 AMERICAS: ANIMAL VACCINES MARKET SHARE, BY REGION 2020 (%)

FIGURE 14 NORTH AMERICA: ANIMAL VACCINES MARKET SHARE, BY COUNTRY 2020 (%)

FIGURE 15 EUROPE: ANIMAL VACCINES MARKET SHARE (%), BY REGION, 2020

FIGURE 16 WESTERN EUROPE: ANIMAL VACCINES MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 17 ASIA-PACIFIC: ANIMAL VACCINES MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 18 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET SHARE (%), BY REGION, 2020

FIGURE 19 EXPANSION: THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ANIMAL VACCINES MARKET

FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 21 REVENUE OF MAJOR PLAYERS, 2020

FIGURE 22 MAJOR PLAYERS R&D EXPENDITURE, 2020

FIGURE 23 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SWOT ANALYSIS

FIGURE 25 ZOETIS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 ZOETIS INC.: SWOT ANALYSIS

FIGURE 27 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 MERCK & CO., INC.: SWOT ANALYSIS

FIGURE 29 ELANCO ANIMAL HEALTH INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 ELANCO ANIMAL HEALTH INCORPORATED: SWOT ANALYSIS

FIGURE 31 VIRBAC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 VIRBAC: SWOT ANALYSIS

FIGURE 33 PHIBRO ANIMAL HEALTH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 NEOGEN CORPORATION: FINANCIAL OVERVIEW SNAPSHOT


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com